In the UK, the regulatory pathway for new medicines requires the MHRA to assess comprehensive evidence of safety, efficacy, and quality before granting a marketing authorisation
dulaglutide (Trulicity) for the treatment of type 2 diabetes (7% of 2025 revenues)
One compound that has garnered attention in recent years is glutathione
Candidates Ideal candidates for semaglutide are individuals who have been diagnosed with type 2 diabetes or who struggle with obesity
Bottom Line GLP-1 medications like Ozempic, Wegovy, Mounjaro, Zepbound, and others have transformed diabetes and weight-management care
It is an absolutely indispensable addition to modern peptide libraries focused on next-generation metabolic research, cellular energy dynamics, and comprehensive endocrine health